APA

Raslová K., Tamer S. C., Clauson P. & Karl D. (20070614). Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index. : Clinical drug investigation.

Chicago

Raslová Katarina, Tamer Soren Can, Clauson Per and Karl Diane. 20070614. Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index. : Clinical drug investigation.

Harvard

Raslová K., Tamer S. C., Clauson P. and Karl D. (20070614). Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index. : Clinical drug investigation.

MLA

Raslová Katarina, Tamer Soren Can, Clauson Per and Karl Diane. Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index. : Clinical drug investigation. 20070614.